Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse.
about
Role of cues and contexts on drug-seeking behaviourRational development of addiction pharmacotherapies: successes, failures, and prospectsUpdate on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor AntagonismNew treatments for cocaine dependence: a focused reviewRole of Dopamine 2 Receptor in Impaired Drug-Cue Extinction in Adolescent RatsThe neuropharmacology of relapse to food seeking: methodology, main findings, and comparison with relapse to drug seeking.Phenylpiperazine derivatives with selectivity for dopamine D3 receptors modulate cocaine self-administration in ratsAripiprazole Facilitates Extinction of Conditioned Fear in Adolescent Rats.Dopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development.Anti-relapse medications: preclinical models for drug addiction treatment.Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm--possible influence of self-control.Activators of G-protein signaling 3: a drug addiction molecular gateway.Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models.Inactivation of the bed nucleus of the stria terminalis in an animal model of relapse: effects on conditioned cue-induced reinstatement and its enhancement by yohimbine.Modafinil effects on reinstatement of methamphetamine seeking in a rat model of relapse.Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapseChronic cocaine self-administration attenuates the anxiogenic-like and stress potentiating effects of the benzodiazepine inverse agonist, FG 7142.Aripiprazole maintenance increases smoked cocaine self-administration in humans.Oxytocin differentially affects sucrose taking and seeking in male and female ratsEnhancement of cue-induced reinstatement of cocaine-seeking in rats by yohimbine: sex differences and the role of the estrous cycle.NMDA receptor blockade in the basolateral amygdala disrupts consolidation of stimulus-reward memory and extinction learning during reinstatement of cocaine-seeking in an animal model of relapse.Oral administration of levo-tetrahydropalmatine attenuates reinstatement of extinguished cocaine seeking by cocaine, stress or drug-associated cues in rats.A comparison of the effects of different operant training experiences and dietary restriction on the reinstatement of cocaine-seeking in rats.Loss of D2 dopamine receptor function modulates cocaine-induced glutamatergic synaptic potentiation in the ventral tegmental area.Controversies in translational research: drug self-administration.The effectiveness of treatments for cocaine dependence in schizophrenic patients: a systematic review.Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration.Extended methamphetamine self-administration enhances reinstatement of drug seeking and impairs novel object recognition in rats.Assessment of a proposed "three-criteria" cocaine addiction model for use in reinstatement studies with rats.Efficacy of the atypical antipsychotic aripiprazole in d-amphetamine-based preclinical models of mania.Aripiprazole for cocaine abstinence: a randomized-controlled trial with ecological momentary assessment.Cue-induced resumption of heroin and cocaine seeking in rats using a conflict model of abstinence and relapse.Alterations in behavioral responses to dopamine agonists in olfactory bulbectomized mice: relationship to changes in the striatal dopaminergic system.Bifeprunox: a partial agonist at dopamine D2 and serotonin 1A receptors, influences nicotine-seeking behaviour in response to drug-associated stimuli in rats.Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans.Cariprazine (RGH-188), a D₃-preferring dopamine D₃/D₂ receptor partial agonist antipsychotic candidate demonstrates anti-abuse potential in rats.Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on clinical status, substance craving, and quality of life.
P2860
Q26825476-BEDC6291-CEE9-45D3-ADEC-69546B14FF80Q27025533-77E5D132-7A2C-49D3-AB9E-1103500B0598Q28084069-ACDD8CEF-14F1-40BD-9F41-D69CB0AB4D00Q28252765-2E17605B-0CBB-484F-9F03-D4BD8C9BD2AAQ28273912-465F08B2-3284-444C-A9AD-3E1E5D92E63CQ30479808-8E4418FA-C3AE-4275-A238-4DCC74D209FEQ30581703-59654DE8-726C-4052-94E2-36F520AA35E6Q33650040-42A47F71-57F5-4AD7-8F7A-1AA0EEB3822AQ33697312-FE4C9D3D-BDA4-47EC-8511-127DF3A964FEQ33927470-A4CC91C3-D321-4986-922C-46601EE36656Q34013720-AD18CB21-E48B-4344-8DD5-F030C784461DQ34235593-AECC0EF1-726C-4501-93B5-62F24E706CC7Q34407185-5787B074-0A94-402C-A0F8-68167E9A3005Q34623281-C69EB3C3-B8A8-499F-AB4C-3CD7B95FBE87Q34795068-1AD9A991-8CEF-47F8-8A15-355FFA4CF855Q35062881-00831113-265F-4D8F-85A8-1941A398F909Q35085940-73BC6C34-7E72-4017-8B8B-656C0675C38AQ35098039-A120ACF8-04C3-488B-933E-5A6046AE4D93Q35295424-6AF88FD6-245F-4B9B-94EB-40855EB91001Q35368602-705F918D-F0B0-49B8-889B-252FBE5CF3B6Q36149010-984C7EB6-DD2E-4F38-B7EA-66B33D8DAA88Q36303094-857F673B-0668-4B45-95D0-C156D093BBEEQ36495330-0668BDA7-E726-4E17-A8C0-621F2D7FBD81Q37041574-3CA0D6FC-75A4-42F7-A1C7-9ACF92EF98ABQ37087986-BD825DAD-2250-4D93-BD0D-8FB230BC8FE7Q37149014-0567CD87-C595-4C02-BAE9-9294BF6241FEQ37353914-49F3AC66-1545-4697-85D9-1320B841F830Q37355338-92044EE4-9C27-47CC-B3D8-C1A15C233D6AQ38194926-ED076B92-EBE9-4DCC-88E5-9AC63D89656DQ43202778-F68F4EC9-C0E8-47C9-9D00-93AE76D8753EQ47392599-A0EF7928-C130-49C8-BD52-A5C46629F974Q47896565-DF7CFF17-6253-4EF8-A216-042C9053FC2DQ48064453-703D2E5E-1339-49CD-9D6A-4EEC1A391FF8Q48139910-DED17B2F-9546-473A-B9DF-1C6C24AA8EA1Q48318789-DFABD3A5-55FE-40EC-9D94-F3DAFD572C6CQ52301734-069E27DD-3A44-450C-AF4B-E92F4D22655AQ55443557-B2572FAF-8235-4EC9-A462-004B8B8CDA6F
P2860
Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse.
@ast
Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse.
@en
Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse.
@nl
type
label
Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse.
@ast
Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse.
@en
Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse.
@nl
prefLabel
Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse.
@ast
Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse.
@en
Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse.
@nl
P2093
P1476
Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse.
@en
P2093
C Anthony Altar
Matthew W Feltenstein
Ronald E See
P304
P356
10.1016/J.BIOPSYCH.2006.04.010
P407
P577
2006-06-27T00:00:00Z